Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Advances in Rheumatology (London, England)|January 23, 2025
COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six monthsClaudia Marques, Marcelo M Pinheiro, Jennifer Lopes, et al.
Vaccines|November 26, 2025
Primary and Booster COVID-19 Vaccination in Patients with Sjögren's Disease: Data from the Longitudinal SAFER Cohort StudyMaressa Barbosa Beloni Lirio, Ketty Lysie Libardi Lira Machado, Olindo Assis Martins-Filho, et al.
Advances in Rheumatology (London, England)|November 22, 2025
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohortPriscila Dias Cardoso Ribeiro, Flavia Maria Matos Melo Campos Peixoto, Edgard Torres Dos Reis-Neto, et al.
Advances in Rheumatology (London, England)|May 3, 2022
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registryAna Paula Monteiro Gomides, Cleandro Pires de Albuquerque, Licia Maria Henrique da Mota, et al.
Advances in Rheumatology (London, England)|October 10, 2024
Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and BrazilMarco Ulises Martinez-Martinez, Carolina Ayelen Isnardi, Deshiré Alpizar-Rodriguez, et al.
Vaccines|September 28, 2024
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-StudyDébora Cerqueira Calderaro, Valéria Valim, Gilda Aparecida Ferreira, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 8, 2023
Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and BrazilCarolina Ayelen Isnardi, Deshire Alpizar-Rodriguez, Débora Cerqueira Calderaro, et al.
Advances in Rheumatology (London, England)|January 18, 2022
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task forceAnna Carolina Faria Moreira Gomes Tavares, Ana Karla Guedes de Melo, Vítor Alves Cruz, et al.
Vaccines|January 8, 2025
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER CohortKetty Lysie Libardi Lira Machado, Ana Paula Neves Burian, Olindo Assis Martins-Filho, et al.
Pageof 5